Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Monday, March 20, 2023.

Altamira Therapeutics Ltd. - Common Shares (NASDAQ:CYTO)

Strong Downtrend (-100) - CYTO is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, CYTO continues to fall. Traders should use caution and set stops.

Is it time to buy, sell, or avoid CYTO?

MarketClub looks at technical strength and momentum to determine if the timing is right for CYTO.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

NASDAQ_CYTO
Open High Low CYTO Price Change
1.43 1.43 1.27 1.35 -0.09
Entry Signal

MarketClub’s Trade Triangles for CYTO

long term down The long-term trend has been DOWN since Jun 10th, 2022 at 0.6208

intermediate term down The intermediate-term trend has been DOWN since Mar 6th, 2023 at 2.2601

short term down The short-term trend has been DOWN since Mar 10th, 2023 at 1.2500

Smart Scan Analysis for CYTO

Based on our trend formula, CYTO is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

-100
Smart Scan Analysis for CYTO
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
1.43 1.43 1.27 1.35 -0.09
Prev. Close Volume Bid Ask Time
1.35 88059 2023-03-17 15:59:50
52wk High4352wk High Date2022-04-11
52wk Low1.252wk Low Date2023-03-10
Average Volume1,635,927Shares Outstanding571
Assets18,838,598MLiabilities6,134,070M
P/E Ratio-1.90960000
Get a free daily analysis and signals for Altamira Therapeutics Ltd. - Common Shares (CYTO) - Request Your Free Report.